# Hypertension and age‐related focal global glomerulosclerosis are associated with biomarkers for cellular senescence

**Authors:** Michael D. Hughson, Alaa A. Ali, Yusuke Okabayashi, Victor G. Puelles, John F. Bertram

PMC · DOI: 10.14814/phy2.70730 · 2026-01-29

## TL;DR

This study finds that hypertension and aging are linked to kidney damage and signs of cellular aging.

## Contribution

The study identifies cellular senescence markers associated with hypertension and aging-related kidney damage.

## Key findings

- Podocyte numbers decrease with increased senescence markers in glomeruli undergoing tuft contraction.
- Hypertensive kidneys show higher frequencies of tuft contraction and global glomerulosclerosis.
- Senescence markers like p16 and p21 are elevated in tubular atrophy caused by hypertension.

## Abstract

Arterionephrosclerosis is characterized by focal global glomerulosclerosis (FGGS), which is a constant feature of aging and hypertension. FGGS begins as normal‐appearing glomeruli that undergo tuft contraction (TC) and progress to global glomerulosclerosis (GGS). Kidney tissue from 26 hypertensive and 25 age‐matched non‐hypertensive patients was analyzed for glomerular volume and for podocyte number using a WT1 antibody. Immunohistochemistry (IHC) was employed to detect the senescence‐related biomarkers p16, p21, β‐galactosidase (GLB1), and 5‐nucleotidase (CD73). Antibodies against annexin 3 (ANXA3), cytokeratin 7, and CD44 were used to evaluate parietal epithelial cell (PEC) activation. The relationships between biomarkers, hypertension, TC, and GGS were quantitatively analyzed. With TC, podocyte numbers decreased in association with increased glomerular p16, p21, GLB1, and CD73 expression. With TC, WT1, CK7, and CD44‐expressing PEC increased. TC and GGS expressed senescent markers in hypertensive and non‐hypertensive kidneys; however, the frequency of TC (p < 0.01) and GGS (p < 0.001) was greater in hypertensive kidneys, and glomerular expression of senescence markers was correspondingly higher. Additionally, greater p16 and p21 expression was observed in the tubular atrophy of hypertension. As FGGS developed, podocyte depletion, cellular senescence markers, and PEC activation were associated with TC and increased with hypertension.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026], GLB1 (galactosidase beta 1) [NCBI Gene 2720], NT5E (5'-nucleotidase ecto) [NCBI Gene 4907], WT1 (WT1 transcription factor) [NCBI Gene 7490], KRT7 (keratin 7) [NCBI Gene 3855], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], ANXA3 (annexin A3) [NCBI Gene 306]

## Full-text entities

- **Genes:** KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, WT1 (WT1 transcription factor) [NCBI Gene 7490] {aka AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Anxa3 (annexin A3) [NCBI Gene 11745] {aka Anx3}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, Krt7 (keratin 7) [NCBI Gene 110310] {aka D15Wsu77e, K7, Krt2-7}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, ANXA3 (annexin A3) [NCBI Gene 306] {aka ANX3}
- **Diseases:** TC (MESH:C536924), Arteriolosclerosis (MESH:D050379), proteinuria (MESH:D011507), GGS (MESH:D001037), fibrosis (MESH:D005355), primary (MESH:D010538), tumor (MESH:D009369), atrophy (MESH:D001284), segmental sclerosis lesions (MESH:C537538), obese (MESH:D009765), sclerosing (MESH:D012598), FGGS (MESH:D005923), atrophic (MESH:D020966), intimal hyperplasia (MESH:D006965), thrombosis (MESH:D013927), Chronic hypertension (MESH:D006973), hypertensive kidney (MESH:D007680), arteriosclerosis (MESH:D001161), ESKD (MESH:D007676), hypertrophy (MESH:D006984), glomerular diseases (MESH:D007674), glomerulosclerosis (MESH:D005921), inflammation (MESH:D007249), diabetes (MESH:D003920), AAA (MESH:C565230), CKD (MESH:D012080), glomerular ischemia (MESH:D007511), hypertensive nephrosclerosis (MESH:D009400), neoplastic disease (MESH:D004194)
- **Chemicals:** creatinine (MESH:D003404), DAB (-), Alexa Fluor 647 (MESH:C569686), Periodic acid (MESH:D010504), ADP (MESH:D000244), formalin (MESH:D005557), DAPI (MESH:C007293), aldosterone (MESH:D000450), hematoxylin (MESH:D006416), paraffin (MESH:D010232), H (MESH:D006859), oil (MESH:D009821), Alexa Fluor 555 (MESH:C000608607), ATP (MESH:D000255), AMP (MESH:D000249), PAS (MESH:D011478)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** NCL-L — Homo sapiens (Human), Embryonic stem cell (CVCL_A002)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12856055/full.md

---
Source: https://tomesphere.com/paper/PMC12856055